CRGX CARGO Therapeutics
- 20.370
- +0.870+4.46%
- 20.370
- 0.0000.00%
CARGO Therapeutics News
J.P. Morgan Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $30
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $32
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Cuts Target Price to $34
Cargo Therapeutics Analyst Ratings
Piper Sandler Maintains Overweight on Cargo Therapeutics, Lowers Price Target to $34
H.C. Wainwright Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $33
CARGO Therapeutics Price Target Announced at $33.00/Share by HC Wainwright & Co.
Cargo Therapeutics Analyst Ratings
Cargo Therapeutics Analyst Ratings
Buy Rating Affirmed for CARGO Therapeutics on Promising CAR-T Advancements and Strategic Positioning
Chardan Initiates CARGO Therapeutics at Buy With $28 Price Target
Cargo Therapeutics Analyst Ratings
Cargo Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: CARGO Therapeutics, Inc. (CRGX), Helius Medical Technologies (HSDT) and CareCloud (CCLD)
Buy Rating Affirmed for CARGO Therapeutics on Robust Trial Progress and Strong Market Potential
JPMorgan Initiates Cargo Therapeutics at Overweight Rating With $23 Price Target
Jefferies Initiates Coverage On Cargo Therapeutics With Buy Rating, Announces Price Target of $28
Cargo Therapeutics Analyst Ratings
Buy Rating Affirmed for CARGO Therapeutics on Strong CRG-022 Phase 1 Results and Market Potential
Analysis
Price Target
No Data
No Data